SAVE THE DATE Investor Day 8 November 2018 13.30

London, 18 July 2018 – Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody’s / BB+ S&P, both stable) will host an Investor Day on 8 November 2018 at 13.30 at Bank of America Merrill Lynch Financial Centre, 2 King Edward Street, London EC1A 1HQ.

Press Release Corporate 18 July 2018

The event will be hosted by Siggi Olafsson, Chief Executive Officer, supported by Hikma’s management team.

If you are interested in attending please contact Carissa Gilbert on 020 3727 1861 or via email to to register for further details.

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.